In competing risk Cox regression models, CHIP was an independent predictor for the development of cardiomyopathy (HR: 2.01; 95% CI: 1.03-3.93; P = 0.042) after adjusting for CAD, cardiovascular risk factors, and oncologic therapies (Figure 1B). Here, STUB1 is linked to cardiomyopathy.